Next, subgroup analyses were carried out and we found that the CV, all-cause, and atherosclerotic CV mortality significantly increased with the elevation of apo B/apo A1 ratio levels in all predesignated subgroups except in patients without diabetes (Supplementary Figure 1). This evidence concerns the gene APOB and diabetes mellitus.